China Shineway Pharmaceutical Group has a Cash Ratio of 3.01. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.
CSWYY's Cash Ratio is ranked better than 85.54% of 975
companies
in the Drug Manufacturers industry
Industry Median: 0.61
vs CSWYY: 3.01
China Shineway Pharmaceutical Group (OTCPK:CSWYY) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
China Shineway Pharmaceutical Group Cash Ratio Related Terms
China Shineway Pharmaceutical Group Cash Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Shineway Pharmaceutical Group Cash Ratio Chart
For the Drug Manufacturers - Specialty & Generic subindustry, China Shineway Pharmaceutical Group's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Shineway Pharmaceutical Group Cash Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China Shineway Pharmaceutical Group's Cash Ratio distribution charts can be found below:
* The bar in red indicates where China Shineway Pharmaceutical Group's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Shineway Pharmaceutical Group (CSWYY) has a Cash Ratio of 3.01 as of Dec. 2025. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on China Shineway Pharmaceutical Group and its competitors. This is 10% below median its historical median of 3.33. Over the past decade, China Shineway Pharmaceutical Group's Cash Ratio has ranged from 2.43 to 4.98. According to the industry distribution chart, China Shineway Pharmaceutical Group ranks #141 out of 975 companies in the Drug Manufacturers industry, placing it in the top 14.5%.
Is China Shineway Pharmaceutical Group's Cash Ratio too high?
China Shineway Pharmaceutical Group's current Cash Ratio of 3.01 is 10% below median its 10-year median of 3.33. Over the past 10 years, this metric has ranged from a low of 2.43 to a high of 4.98. The Drug Manufacturers industry median Cash Ratio is 0.61. China Shineway Pharmaceutical Group's value of 3.01 is 393.4% above this industry median. Based on the distribution chart, China Shineway Pharmaceutical Group ranks #141 out of 975 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, China Shineway Pharmaceutical Group has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does China Shineway Pharmaceutical Group's Cash Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, China Shineway Pharmaceutical Group ranks #141 out of 975 companies for Cash Ratio. This places China Shineway Pharmaceutical Group in the top 15% of its industry — outperforming the majority of peers. The industry median Cash Ratio is 0.61. China Shineway Pharmaceutical Group's value of 3.01 is 393.4% above this benchmark. Historically, China Shineway Pharmaceutical Group's own Cash Ratio has ranged from 2.43 to 4.98 over the past decade. While the company's 10-year median is 3.33 vs. the industry median of 0.61, China Shineway Pharmaceutical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Drug Manufacturers company?
The median Cash Ratio among Drug Manufacturers companies is 0.61, based on 975 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Shineway Pharmaceutical Group's current Cash Ratio of 3.01 is 393.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on China Shineway Pharmaceutical Group and its competitors. For the Drug Manufacturers industry, the median Cash Ratio is 0.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Shineway Pharmaceutical Group's current Cash Ratio is 3.01, which is 10% below median its own 10-year median of 3.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Shineway Pharmaceutical Group stock overvalued right now?
China Shineway Pharmaceutical Group (CSWYY) has a current Cash Ratio of 3.01. The stock's GF Value™ is $17.03, compared to a current price of $19.25 — trading 13% above its estimated fair value. The current Cash Ratio is 3.01, which is 10% below median its 10-year median of 3.33 and 393.4% above the Drug Manufacturers industry median of 0.61. China Shineway Pharmaceutical Group's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For China Shineway Pharmaceutical Group (CSWYY), the current Cash Ratio is 3.01 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Shineway Pharmaceutical Group (CSWYY) Overvalued in 2026?
Based on GuruFocus' analysis, China Shineway Pharmaceutical Group stock appears to be overvalued.
The current stock price of $19.25 is trading 13% above its estimated GF Value™ of $17.03.
Key valuation signals for CSWYY:
Cash Ratio: 3.01 (10% below median its 10-year median of 3.33)
GF Value™: $17.03 vs. price of $19.25 (13% above fair value)
Industry Position: 393.4% above the Drug Manufacturers median (#141 of 975)
No single metric tells the full story. See the CSWYY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Shineway Pharmaceutical Group Business Description
China Shineway Pharmaceutical Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, traditional Chinese medicine formula granules, and others, of which injections generate maximum revenue for the company. Geographically, the group operates in the People's Republic of China (PRC) and Hong Kong.
92GF Score
Get the complete analysis for CSWYY
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSWYY has been successfully added to your 
